BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22875905)

  • 1. Varicella postexposure prophylaxis in children with cancer: urgent need for a randomised controlled trial.
    Bate J; Chisholm J; Skinner R; Breuer J; Ramsay M; Wheatley K; Hambleton S; Heath PT
    Arch Dis Child; 2012 Sep; 97(9):853-4. PubMed ID: 22875905
    [No Abstract]   [Full Text] [Related]  

  • 2. Postexposure chickenpox prophylaxis in children with leukaemia: a reply to the recent PEPtalk study and report of a service evaluation in a tertiary paediatric haematology centre in the UK.
    Samuelson CV; Rambani R; Vora AJ
    Arch Dis Child; 2012 Aug; 97(8):759-60. PubMed ID: 22523432
    [No Abstract]   [Full Text] [Related]  

  • 3. PEPtalk: postexposure prophylaxis against varicella in children with cancer.
    Bate J; Chisholm J; Heath PT; Breuer J; Skinner R; Manley S; Patel S; Wheatley K; Ramsay M; Kearns PR; Hambleton S
    Arch Dis Child; 2011 Sep; 96(9):841-5. PubMed ID: 21715391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing varicella in children with malignancies: what is the evidence?
    Fisher JP; Bate J; Hambleton S
    Curr Opin Infect Dis; 2011 Jun; 24(3):203-11. PubMed ID: 21455062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.
    Bate J; Baker S; Breuer J; Chisholm JC; Gray J; Hambleton S; Houlton A; Jit M; Lowis S; Makin G; O'Sullivan C; Patel SR; Phillips R; Ransinghe N; Ramsay ME; Skinner R; Wheatley K; Heath PT
    Arch Dis Child; 2019 Jan; 104(1):25-29. PubMed ID: 29730641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Revised multidisciplinary guidelines 'Varicella'; broader indication for post-exposure prophylaxis].
    van Kampen JJA; Bruns AHW; van Leeuwen E; Koelewijn JM; Ruijs WLM; Komen DJC; Vermont CL; Opstelten W
    Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32779924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of VariZIG in pregnancy.
    Bapat P; Koren G
    Expert Rev Vaccines; 2013 Nov; 12(11):1243-8. PubMed ID: 24093779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of varicella vaccines as postexposure prophylaxis.
    Brotons M; Campins M; Méndez L; Juste C; Rodrigo JA; Martínez X; Hermosilla E; Pinós L; Vaqué J
    Pediatr Infect Dis J; 2010 Jan; 29(1):10-3. PubMed ID: 19841607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in practice remains in the UK management of varicella postexposure prophylaxis in children with cancer.
    Jarrold K; Bate J
    Arch Dis Child; 2019 Jan; 104(1):101. PubMed ID: 29743174
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin.
    Cohen A; Moschopoulos P; Stiehm RE; Koren G
    CMAJ; 2011 Feb; 183(2):204-8. PubMed ID: 21262937
    [No Abstract]   [Full Text] [Related]  

  • 11. Updated recommendations for use of VariZIG--United States, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jul; 62(28):574-6. PubMed ID: 23863705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-exposure varicella prophylaxis].
    Johansen JS; Westergren T; Lingaas E
    Tidsskr Nor Laegeforen; 2011 Sep; 131(17):1645-8. PubMed ID: 21901036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.
    Levin MJ; Duchon JM; Swamy GK; Gershon AA
    PLoS One; 2019; 14(7):e0217749. PubMed ID: 31269033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against varicella as post-exposure prophylaxis in adults: a quantitative assessment.
    Souty C; Boos E; Turbelin C; Blanchon T; Hanslik T; Boëlle PY
    Vaccine; 2015 Jan; 33(3):446-50. PubMed ID: 25475956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong.
    Chui KS; Wu HL; You JH
    Scand J Infect Dis; 2014 Jan; 46(1):27-33. PubMed ID: 24228821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VariZIG for prophylaxis after exposure to varicella.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):69-70. PubMed ID: 16977283
    [No Abstract]   [Full Text] [Related]  

  • 17. A Decade of Varicella Screening Within a Paediatric Inflammatory Bowel Disease Population.
    Harris RE; Curtis L; Hegde V; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
    J Crohns Colitis; 2020 Jun; 14(5):608-616. PubMed ID: 31889176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Varicella vaccination].
    Heidl M; Scholz H
    Padiatr Grenzgeb; 1990; 29(1):31-6. PubMed ID: 2160635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chickenpox in the immunocompromised child.
    Roderick M; Finn A; Ramanan AV
    Arch Dis Child; 2012 Jul; 97(7):587-9. PubMed ID: 22563036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of varicella vaccine as post exposure prophylaxis in Chilean children].
    Pinochet C; Cerda J; Hirsch T; Mieres J; Inostroza C; Abarca K
    Rev Chilena Infectol; 2012 Dec; 29(6):635-40. PubMed ID: 23412032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.